![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
SK Mishra and K Hermsmeyer
Oregon Regional Primate Research Center, Beaverton.
Blocking actions of the novel Ca++ antagonist, Ro 40-5967 ((1S,2S)-2- [2[[3-(2-benzimidazolylpropyl] methylamino]ethyl]-6-fluoro-1,2,3,4- tetrahydro-1-isopropyl-2-++naphthyl+ ++ methoxyacetate dihydrochloride), on divalent inward currents were characterized in spontaneously active vascular muscle cells (VMC) of neonatal rat azygos veins. Ca++ channel currents (ICa) were reduced by Ro 40-5967 in a concentration range from 0.1 to 10 microM, effective within the first 5 min of exposure. ICa were decreased by up to 70% during the first stimulus test pulse and remained constant during subsequent pulses, and were not shifted along the voltage axis, as determined by peak current- voltage plots. There was no change in apparent threshold or the voltage (+20 mV) at which maximum inward current occurred. Block of Ba++ currents through VMC Ca++ channels occurred independent of membrane potential, even when holding potential was as negative as -80 mV. ICa were blocked to the same absolute values from holding potential = -30 mV. Thus, ICa block occurred equally during the first pulse and at all subsequent time points, i.e., under conditions in which VMC Ca++ channels were in the resting state, inactive state, or open state. To search further for use-dependent effects of Ro 40-5967, we stimulated at higher frequencies (up to 0.3/sec), but there was no change in fractional block with frequency or stimulus repetition and thus no use dependence of the block of VMC Ca++ channels by Ro 40-5967.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  M. M. McNulty and D. A. Hanck State-Dependent Mibefradil Block of Na+ Channels Mol. Pharmacol., December 1, 2004; 66(6): 1652 - 1661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Martin, J.-H. Lee, L. L. Cribbs, E. Perez-Reyes, and D. A. Hanck Mibefradil Block of Cloned T-Type Calcium Channels J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 302 - 308. [Abstract] [Full Text]
|
|
|
|
|
|
J. C. Gomora, L. Xu, J. A. Enyeart, and J. J. Enyeart Effect of Mibefradil on Voltage-Dependent Gating and Kinetics of T-Type Ca2+ Channels in Cortisol-Secreting Cells J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 96 - 103. [Abstract] [Full Text]
|
|
|
|
|
|
J. C. Gomora, J. A. Enyeart, and J. J. Enyeart Mibefradil Potently Blocks ATP-Activated K+ Channels in Adrenal Cells Mol. Pharmacol., December 1, 1999; 56(6): 1192 - 1197. [Abstract] [Full Text]
|
|
|
|
 |
|
 U. C. Luft, R. Bychkov, M. Gollasch, V. Gross, J.-B. Roullet, D. A. McCarron, C. Ried, F. Hofmann, Y. Yagil, C. Yagil, et al. Farnesol Blocks the L-Type Ca2+ Channel by Targeting the {alpha}1C Subunit Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 959 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Rossier, E. A. Ertel, M. B. Vallotton, and A. M. Capponi Inhibitory Action of Mibefradil on Calcium Signaling and Aldosterone Synthesis in Bovine Adrenal Glomerulosa Cells J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 824 - 831. [Abstract] [Full Text]
|
|
|
|
|
|
S. I. McDonough and B. P. Bean Mibefradil Inhibition of T-Type Calcium Channels in Cerebellar Purkinje Neurons Mol. Pharmacol., December 1, 1998; 54(6): 1080 - 1087. [Abstract] [Full Text]
|
|
|
|
|
|
C. Arnoult, M. Villaz, and H. M. Florman Pharmacological Properties of the T-Type Ca2+ Current of Mouse Spermatogenic Cells Mol. Pharmacol., June 1, 1998; 53(6): 1104 - 1111. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
